Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Magliocco AM"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 24
Tytuł:
Copy number analysis of c-erb-B2 (HER-2/neu) and topoisomerase IIalpha genes in breast carcinoma by quantitative real-time polymerase chain reaction using hybridization probes and fluorescence in situ hybridization.
Autorzy:
Murthy SK (AUTHOR)
Magliocco AM (AUTHOR)
Demetrick DJ (AUTHOR)
Pokaż więcej
Źródło:
Archives of Pathology & Laboratory Medicine. Jan2005, Vol. 129 Issue 1, p39-46. 8p.
URL:
16012407  Link otwiera się w nowym oknie
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Utilizing digital pathology to quantify stromal caveolin-1 expression in malignant and benign ovarian tumors: Associations with clinicopathological parameters and clinical outcomes.
Autorzy:
Saeed-Vafa D; Department of Anatomic Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America.
Marchion DC; Tissue Core-Biospecimen Processing Laboratory, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America.
McCarthy SM; Department of Anatomic Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America.
Hakam A; Department of Anatomic Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America.
Lopez A; Department of Anatomic Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America.
Wenham RM; Department of Gynecologic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America.
Apte SM; Department of Gynecologic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America.
Chen DT; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America.
Magliocco AM; Department of Anatomic Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America.
Lancaster JM; Department of Gynecologic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America.
Reid BM; Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America.
Permuth JB; Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Nov 23; Vol. 16 (11), pp. e0256615. Date of Electronic Publication: 2021 Nov 23 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Caveolin 1/*metabolism
Cystadenocarcinoma, Serous/*metabolism
Ovarian Neoplasms/*metabolism
Ovary/*metabolism
Stromal Cells/*metabolism
Adult ; Aged ; Aged, 80 and over ; Biomarkers, Tumor/metabolism ; Cystadenocarcinoma, Serous/mortality ; Cystadenocarcinoma, Serous/pathology ; Down-Regulation ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Immunohistochemistry ; Middle Aged ; Neoplasm Staging ; Ovarian Neoplasms/mortality ; Ovarian Neoplasms/pathology ; Ovary/pathology ; Stromal Cells/pathology ; Survival Rate ; Tissue Array Analysis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Expression of the BAD pathway is a marker of triple-negative status and poor outcome.
Autorzy:
Boac BM; Department of Anatomic Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA.; Chemical Biology and Molecular Medicine, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA.
Abbasi F; Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.
Ismail-Khan R; Department of Oncologic Sciences, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA.; Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA.
Xiong Y; Department of Anatomic Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA.; Chemical Biology and Molecular Medicine, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA.
Siddique A; Department of Anatomic Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA.
Park H; Department of Anatomic Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA.; Chemical Biology and Molecular Medicine, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA.
Han M; Department of Anatomic Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA.; Chemical Biology and Molecular Medicine, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA.
Saeed-Vafa D; Department of Anatomic Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA.
Soliman H; Department of Oncologic Sciences, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA.; Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA.
Henry B; Department of Anatomic Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA.
Pena MJ; Department of Anatomic Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA.
McClung EC; University of Arizona Cancer Center, Obstetrics and Gynecology, Tucson, AZ, 85724, USA.
Robertson SE; Indiana University Health, Indianapolis, IN, 46202, USA.
Todd SL; Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA.
Lopez A; Department of Anatomic Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA.
Sun W; Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA.
Apuri S; Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA.
Lancaster JM; Myriad Genetics, Salt Lake City, UT, 84108, USA.
Berglund AE; Department of Bioinformatics and Biostatistics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA.
Magliocco AM; Protean Diagnostics, Tampa, FL, 33612, USA.
Marchion DC; Department of Anatomic Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA. .; Chemical Biology and Molecular Medicine, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2019 Nov 25; Vol. 9 (1), pp. 17496. Date of Electronic Publication: 2019 Nov 25.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Gene Regulatory Networks*
Biomarkers, Tumor/*genetics
Biomarkers, Tumor/*metabolism
Gene Expression Profiling/*methods
Triple Negative Breast Neoplasms/*metabolism
Cell Line, Tumor ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Middle Aged ; Oligonucleotide Array Sequence Analysis ; Phosphorylation ; Principal Component Analysis ; Prognosis ; Signal Transduction ; Survival Analysis ; Triple Negative Breast Neoplasms/genetics ; bcl-Associated Death Protein/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Body Mass Index Genetic Risk Score and Endometrial Cancer Risk.
Autorzy:
Prescott J; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.; Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America.
Setiawan VW; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.
Wentzensen N; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America.
Schumacher F; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.
Yu H; Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, United States of America.; Department of Epidemiology and Public Health, Yale Cancer Center, Yale School of Public Health, New Haven, Connecticut, United States of America.
Delahanty R; Division of Epidemiology, Department of Medicine and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Bernstein L; Beckman Research Institute, City of Hope, Duarte, California, United States of America.
Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America.
Chen C; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center and Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington, United States of America.
Cook LS; University of New Mexico, Albuquerque, New Mexico, United States of America.
Friedenreich C; Division of Cancer Care, Department of Population Health Research, Alberta Health Services-Cancer Control Alberta, Calgary, Alberta, Canada.
Garcia-Closas M; Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, United Kingdom.
Haiman CA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.
Le Marchand L; Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, United States of America.
Liang X; Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
Lissowska J; Department of Epidemiology and Cancer Prevention, Cancer Center and M Sklodowska-Curie Institute of Oncology, Warsaw, Poland.
Lu L; Department of Epidemiology and Public Health, Yale Cancer Center, Yale School of Public Health, New Haven, Connecticut, United States of America.
Magliocco AM; H. Lee Moffitt Cancer Centre, Tampa, Florida, United States of America.
Olson SH; Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
Risch HA; Department of Epidemiology and Public Health, Yale Cancer Center, Yale School of Public Health, New Haven, Connecticut, United States of America.
Shu XO; Division of Epidemiology, Department of Medicine and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Ursin G; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.; Cancer Registry of Norway, Oslo, Norway.; Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
Yang HP; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America.
Kraft P; Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America.
De Vivo I; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.; Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2015 Nov 25; Vol. 10 (11), pp. e0143256. Date of Electronic Publication: 2015 Nov 25 (Print Publication: 2015).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Body Mass Index*
Genetic Predisposition to Disease*
Endometrial Neoplasms/*etiology
Obesity/*complications
Obesity/*genetics
Aged ; Case-Control Studies ; Endometrial Neoplasms/epidemiology ; Female ; Genome-Wide Association Study ; Humans ; Middle Aged ; Polymorphism, Single Nucleotide ; Risk ; White People/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The Breast Cancer to Bone (B2B) Metastases Research Program: a multi-disciplinary investigation of bone metastases from breast cancer.
Autorzy:
Brockton NT; Department of Cancer Epidemiology and Prevention Research, CancerControl Alberta, Alberta Health Services, Room 515C, Holy Cross Centre, 2210 2nd St, SW, Calgary, AB, T2S 3C3, Canada. .; Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada. .
Gill SJ; Department of Cancer Epidemiology and Prevention Research, CancerControl Alberta, Alberta Health Services, Room 515C, Holy Cross Centre, 2210 2nd St, SW, Calgary, AB, T2S 3C3, Canada.; Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Laborge SL; Department of Cancer Epidemiology and Prevention Research, CancerControl Alberta, Alberta Health Services, Room 515C, Holy Cross Centre, 2210 2nd St, SW, Calgary, AB, T2S 3C3, Canada.
Paterson AH; Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.; Division of Medical Oncology, Tom Baker Cancer Centre, Cancer Control Alberta, Alberta Health Services, Calgary, Alberta, Canada.
Cook LS; Department of Cancer Epidemiology and Prevention Research, CancerControl Alberta, Alberta Health Services, Room 515C, Holy Cross Centre, 2210 2nd St, SW, Calgary, AB, T2S 3C3, Canada.; Division of Epidemiology, Biostatistics and Preventive Medicine, Department of Internal Medicine, University of New Mexico, Albuquerque, New Mexico, USA.
Vogel HJ; Department of Biological Sciences, Faculty of Science, University of Calgary, Calgary, Alberta, Canada.
Shemanko CS; Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Hanley DA; Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Magliocco AM; Department of Pathology, Moffitt Cancer Center, Tampa, FL, USA.
Friedenreich CM; Department of Cancer Epidemiology and Prevention Research, CancerControl Alberta, Alberta Health Services, Room 515C, Holy Cross Centre, 2210 2nd St, SW, Calgary, AB, T2S 3C3, Canada.; Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.; Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2015 Jul 10; Vol. 15, pp. 512. Date of Electronic Publication: 2015 Jul 10.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Bone Neoplasms/*metabolism
Bone Neoplasms/*secondary
Breast Neoplasms/*metabolism
Breast Neoplasms/*pathology
Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Bone Neoplasms/genetics ; Breast Neoplasms/genetics ; Cytokines/blood ; Female ; Gene Expression Profiling ; Humans ; Prospective Studies ; Research Design ; Survival Analysis ; Vitamin D/blood
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Infertility and incident endometrial cancer risk: a pooled analysis from the epidemiology of endometrial cancer consortium (E2C2).
Autorzy:
Yang HP; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.
Cook LS; University of New Mexico, Albuquerque, NM 87131, USA.
Weiderpass E; 1] Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, SE-171 77 Stockholm, Sweden [2] Department of Genetic Epidemiology, Folkhälsan Research Center, 00014 Helsinki, Finland [3] Department of Research, Cancer Registry of Norway, N-0304 Oslo, Norway [4] Department of Community Medicine, University of Tromsø, The Arctic University of Norway, 90109 Tromsø, Norway.
Adami HO; 1] Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, SE-171 77 Stockholm, Sweden [2] Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA.
Anderson KE; School of Public Health, University of Minnesota, Minneapolis, MN 55454, USA.
Cai H; Department of Medicine, Division of Epidemiology, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Cerhan JR; Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA.
Clendenen TV; Department of Population Health and NYU Perimutter Cancer Center, New York University School of Medicine, New York, NY 10016, USA.
Felix AS; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.
Friedenreich CM; Alberta Health Services, Calgary, Alberta T2T 5C7, Canada.
Garcia-Closas M; Institute of Cancer Research, Surrey SM2 5NG, UK.
Goodman MT; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Liang X; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Lissowska J; M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, 02-781 Warsaw, Poland.
Lu L; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT 06510, USA.
Magliocco AM; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL33612, USA.
McCann SE; Roswell Park Cancer Institute, Buffalo, NY 14203, USA.
Moysich KB; Roswell Park Cancer Institute, Buffalo, NY 14203, USA.
Olson SH; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Petruzella S; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Pike MC; 1] Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA [2] Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA.
Polidoro S; Human Genetics Foundation, 10126 Turin, Italy.
Ricceri F; Human Genetics Foundation, 10126 Turin, Italy.
Risch HA; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT 06510, USA.
Sacerdote C; 1] Human Genetics Foundation, 10126 Turin, Italy [2] Unit of Cancer Epidemiology, University of Turin and Center for Cancer Prevention, 10124 Turin, Italy.
Setiawan VW; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA.
Shu XO; Department of Medicine, Division of Epidemiology, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Spurdle AB; QIMR Berghofer Medical Research Institute, Herston, Queensland 4029, Australia.
Trabert B; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.
Webb PM; QIMR Berghofer Medical Research Institute, Herston, Queensland 4029, Australia.
Wentzensen N; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.
Xiang YB; Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Xu Y; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Yu H; University of Hawaii Cancer Center, Honolulu, HI 96813, USA.
Zeleniuch-Jacquotte A; Department of Population Health and NYU Perimutter Cancer Center, New York University School of Medicine, New York, NY 10016, USA.
Brinton LA; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.
Pokaż więcej
Źródło:
British journal of cancer [Br J Cancer] 2015 Mar 03; Vol. 112 (5), pp. 925-33. Date of Electronic Publication: 2015 Feb 17.
Typ publikacji:
Journal Article
MeSH Terms:
Endometrial Neoplasms/*epidemiology
Endometrial Neoplasms/*etiology
Infertility, Female/*epidemiology
Adult ; Aged ; Aged, 80 and over ; Cohort Studies ; Female ; Humans ; Logistic Models ; Middle Aged ; Parity ; Risk Factors ; Self Report
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Evaluation of E-cadherin, β-catenin and vimentin protein expression using quantitative immunohistochemistry in nasopharyngeal carcinoma patients.
Autorzy:
Hao D; .
Phan T
Jagdis A
Siever JE
Klimowicz AC
Laskin JJ
Thomson TA
Rose MS
Petrillo SK
Magliocco AM
Lau HY
Pokaż więcej
Źródło:
Clinical and investigative medicine. Medecine clinique et experimentale [Clin Invest Med] 2014 Oct 04; Vol. 37 (5), pp. E320-30. Date of Electronic Publication: 2014 Oct 04.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cadherins/*metabolism
Nasopharyngeal Neoplasms/*metabolism
Vimentin/*metabolism
beta Catenin/*metabolism
Adult ; Biomarkers, Tumor/metabolism ; Disease Progression ; Female ; Humans ; Immunohistochemistry ; Male ; Middle Aged ; Survival Rate
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The prognostic value of HPV status and p16 expression in patients with carcinoma of the anal canal.
Autorzy:
Roldán Urgoiti GB; Department of Medicine and Oncology, University of Calgary, Calgary, Alberta, Canada.
Gustafson K; Department of Oncology, Tom Baker Cancer Centre, Calgary, Alberta, Canada.
Klimowicz AC; Department of Oncology, Tom Baker Cancer Centre, Calgary, Alberta, Canada.
Petrillo SK; Department of Oncology, Tom Baker Cancer Centre, Calgary, Alberta, Canada.
Magliocco AM; Department of Anatomic Pathology, H. Lee Moffitt Cancer Center, Tampa, Florida, United States of America.
Doll CM; Department of Medicine and Oncology, University of Calgary, Calgary, Alberta, Canada.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2014 Oct 01; Vol. 9 (10), pp. e108790. Date of Electronic Publication: 2014 Oct 01 (Print Publication: 2014).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Alphapapillomavirus*/classification
Alphapapillomavirus*/genetics
Gene Expression*
Anus Neoplasms/*genetics
Anus Neoplasms/*virology
Neoplasm Proteins/*genetics
Papillomavirus Infections/*complications
Adult ; Aged ; Aged, 80 and over ; Anus Neoplasms/mortality ; Anus Neoplasms/pathology ; Biomarkers, Tumor ; Cyclin-Dependent Kinase Inhibitor p16 ; Female ; Genotype ; Humans ; Male ; Middle Aged ; Neoplasm Metastasis ; Neoplasm Proteins/metabolism ; Patient Outcome Assessment ; Prognosis ; Tumor Burden
SCR Disease Name:
Anal Canal Carcinoma
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The prognostic impact of a combined carbonic anhydrase IX and Ki67 signature in oral squamous cell carcinoma.
Autorzy:
Klimowicz AC; 1] Department of Oncology, University of Calgary, 1331 - 29 Street NW, Calgary, Alberta, Canada T2N 4N2 [2] Functional Tissue Imaging Unit, Translational Laboratories, Tom Baker Cancer Centre, 1331 - 29 Street NW, Calgary, Alberta, Canada T2N 4N2.
Bose P
Petrillo SK
Magliocco AM
Dort JC
Brockton NT
Pokaż więcej
Źródło:
British journal of cancer [Br J Cancer] 2013 Oct 01; Vol. 109 (7), pp. 1859-66. Date of Electronic Publication: 2013 Sep 05.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antigens, Neoplasm/*metabolism
Carbonic Anhydrases/*metabolism
Carcinoma, Squamous Cell/*metabolism
Ki-67 Antigen/*metabolism
Mouth Neoplasms/*metabolism
bcl-2-Associated X Protein/*metabolism
Apoptosis ; Biomarkers, Tumor/metabolism ; Carbonic Anhydrase IX ; Carcinoma, Squamous Cell/mortality ; Cell Hypoxia ; Drug Resistance, Neoplasm ; Female ; Humans ; Male ; Middle Aged ; Mouth Neoplasms/mortality ; Prognosis ; Survival ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
EGFR tyrosine kinase mutation testing in the treatment of non-small-cell lung cancer.
Autorzy:
Kamel-Reid S; Department of Pathology, The University Health Network, Toronto, ON.
Chong G
Ionescu DN
Magliocco AM
Spatz A
Tsao M
Weng X
Young S
Zhang T
Soulieres D
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2012 Apr; Vol. 19 (2), pp. e67-74.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Simultaneous siRNA targeting of Src and downstream signaling molecules inhibit tumor formation and metastasis of a human model breast cancer cell line.
Autorzy:
Bjorge JD; Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, Alberta, Canada.
Pang AS
Funnell M
Chen KY
Diaz R
Magliocco AM
Fujita DJ
Pokaż więcej
Źródło:
PloS one [PLoS One] 2011 Apr 26; Vol. 6 (4), pp. e19309. Date of Electronic Publication: 2011 Apr 26.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Signal Transduction*
Xenograft Model Antitumor Assays*
Breast Neoplasms/*pathology
Precancerous Conditions/*pathology
Proto-Oncogene Proteins pp60(c-src)/*metabolism
RNA, Small Interfering/*metabolism
Animals ; Apoptosis ; Breast Neoplasms/metabolism ; Cell Adhesion ; Cell Line, Tumor ; Cell Proliferation ; Female ; Gene Knockdown Techniques ; Humans ; Lipids ; Mice ; Mice, SCID ; Neoplasm Metastasis ; Precancerous Conditions/metabolism ; Proto-Oncogene Proteins c-myc/metabolism ; STAT3 Transcription Factor/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 24

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies